Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 42.82 K136.38 K128.63 K160.16 K132.11 K383.15 K 804.05 K Research & development —————— — Operating income -42.82 K-136.38 K-128.63 K-160.16 K-132.11 K-383.15 K -804.05 K Non-Operating Income, Total 0735.94 K2.47 M2.32 M2.05 M2.11 M 8.95 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 0735.94 K2.47 M2.32 M2.05 M2.11 M 8.95 M Unusual income/expense —————— — Pretax income -42.82 K599.56 K2.34 M2.16 M1.92 M1.73 M 8.14 M Equity in earnings —————— — Taxes 000000 0 Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -42.82 K599.56 K2.34 M2.16 M1.92 M1.73 M 8.14 M Discontinued operations —————— — Net income -42.82 K599.56 K2.34 M2.16 M1.92 M1.73 M 8.14 M Dilution adjustment ——2.46 M—2.04 M2.1 M — Preferred dividends ——2.46 M—2.04 M2.1 M — Diluted net income available to common stockholders -42.82 K599.56 K2.34 M2.16 M1.92 M1.73 M 8.14 M Basic earnings per share (Basic EPS) 0.020.080.210.150.120.12 0.6 Diluted earnings per share (Diluted EPS) 00.160.210.090.120.12 0.54 Average basic shares outstanding -40.93 M11.6 M29.34 M21.71 M31.33 M31.33 M — Diluted shares outstanding -54.66 M24.8 M29.86 M21.87 M31.33 M31.33 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —